BAJAJ BROKING
Mankind Pharma acquires Bharat Serums and Vaccines for ₹13,630 crore, enhancing its leadership in women's health and fertility drugs. Mankind Pharma’s share price rose by 1.81% to ₹2143.90, with a market cap close to ₹86,000 crore.
Mankind Pharma's share price today is set to be in the spotlight following the announcement of its acquisition of Bharat Serums and Vaccines (BSV) from Advent International. This move aims to strengthen Mankind Pharma's portfolio in high-entry barrier products and secure its leadership in women's health.
Mankind Pharma has signed a definitive agreement to acquire a 100% stake in Bharat Serums and Vaccines from Advent International, a leading global private equity investor, for an enterprise value of ₹13,630 crore, subject to closing adjustments.
The acquisition aligns with Mankind Pharma's strategy to strengthen its position in the women's health and fertility drug market.
The acquisition of BSV represents a significant milestone for Mankind Pharma. It positions the company as a market leader in the Indian women's health and fertility segment while providing access to high-entry barrier products in critical care.
BSV's established R&D technology platforms and robust branded product portfolio in women's health, fertility, and critical care further enhance Mankind Pharma's capabilities.
Following the acquisition announcement, Mankind Pharma share price rose by over 1.81%, settling at ₹2143.90 on Thursday. The company's market capitalization reached approximately ₹86,000 crore.
Mankind Pharma's stock has nearly doubled in value since its initial public offering (IPO) in May 2023, which raised ₹4,326.36 crore at an IPO price of ₹1,080 per share.
Rajeev Juneja, Vice-chairman and Managing Director of Mankind Pharma, highlighted the substantial opportunities and growth potential in the women's health and fertility segment, driven by structural tailwinds globally.
The acquisition of BSV is expected to propel Mankind Pharma's market leadership and enhance its growth prospects in the high-potential segments.
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Share this article:
Share Market Today | Gift Nifty Signals 100-Point Gap Down, Nifty to Consolidate
06 Sep, 2024 | 4 Min. read
KEC International Secures ₹1,423 Cr Transmission Line Order in Saudi Arabia
06 Sep, 2024 | 1 Min. read
Ashoka Buildcon’s Viva Highways Monetises Pune Land for ₹453 Crore
06 Sep, 2024 | 2 Min. read
Peak Partners To Sell 11% Stake in Indigo Paints via Block Deal
06 Sep, 2024 | 2 Min. read
US Initial Jobless Claims Drop to 227,000 in August.
06 Sep, 2024 | 1 Min. read
Commodities Market Today | WTI Crude Steady at $69.18, Gold Rises 0.8% to $2,546
06 Sep, 2024 | 1 Min. read
Gold Rate Today | Gold Rises 0.8% to $2,546, Silver Gains 2% to $29.14
06 Sep, 2024 | 2 Min. read
Vodafone Idea Share Price Falls 11% After Goldman Sachs Report
06 Sep, 2024 | 1 Min. read
Suzlon Energy Share Price Rises After Corporate Office Sale
06 Sep, 2024 | 1 Min. read
Why is the Stock Market Down Today? Key Factors Explained
06 Sep, 2024 | 1 Min. read
Sona BLW Precision Forgings Plans ₹2,400 Crore QIP at ₹675-700 per Share
05 Sep, 2024 | 1 Min. read
Commodities Market Today | Crude Oil Drops, Brent Hits Low; Gold and Silver Rise
05 Sep, 2024 | 1 Min. read
Analysis to Become a Pro Investor
28 Dec, 2023 | 4 Min. read
Women In Real Estate Investing (Investree)
28 Dec, 2023 | 5 Min. read
How To Check Prudent Corporate Advisory IPO Allotment Status
27 Dec, 2023 | 3 Min. read
How To Boost Credit Score? – Steps to Improve Creditworthiness
27 Dec, 2023 | 4 Min. read
Advantages and Disadvantages of Opening Multiple Demat Accounts
26 Dec, 2023 | 4 Min. read
7th CPC LTC: Leave Travel Concession Rules for Central Government Employees
26 Dec, 2023 | 4 Min. read
7th Pay Commission: House Building Advance (HBA) Interest Rate FY 2023-24
26 Dec, 2023 | 5 Min. read
The Future of Trading: Exploring Bajaj Broking’s Demat Features
26 Dec, 2023 | 6 Min. read
7th Central Pay Commission Cpc Fitment Table
23 Dec, 2023 | 7 Min. read
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading